Validation of a high bleeding risk definition in cancer patients undergoing percutaneous coronary intervention
An adapted version of the ARC-HBR criteria, in which cancer is not a major criterion, effectively delineates cancer patients undergoing PCI who are at HBR. Cancer patients at HBR according to this definition also exhibited a higher mortality risk.
Authors
- Samantha Sartori (ORCID: https://orcid.org/0000-0003-0618-9409)
- Annapoorna Kini (ORCID: https://orcid.org/0000-0002-7189-3307)
- Parasuram Krishnamoorthy (ORCID: https://orcid.org/0000-0002-4560-7346)
- Roxana Mehran (ORCID: https://orcid.org/0000-0002-5546-262X)
- Birgit Vogel (ORCID: https://orcid.org/0000-0002-9896-403X)
- Pedro Moreno (ORCID: https://orcid.org/0000-0003-3745-5845)
- Mauro Gitto (ORCID: https://orcid.org/0000-0002-4936-3860)
- Francesca Maria Di Muro (ORCID: https://orcid.org/0000-0002-2145-6555)
- George Dangas (ORCID: https://orcid.org/0000-0001-7502-8049)
- Prakash Krishnan (ORCID: https://orcid.org/0000-0003-2871-3689)
- Benjamin Bay (ORCID: https://orcid.org/0000-0002-4927-8033)
- Joseph Sweeny (ORCID: https://orcid.org/0000-0001-7743-1632)
- Sean Gilhooley
- Angelo Oliva (ORCID: https://orcid.org/0000-0003-0561-7563)
- Kenneth F. Smith (ORCID: https://orcid.org/0009-0009-2646-1933)
- Sanjeev Sharma (ORCID: https://orcid.org/0000-0002-3273-0708)
Institutions
- Humanitas University (IT)
- Mount Sinai Hospital (US)
- Icahn School of Medicine at Mount Sinai (US)
Publication Details
- Journal
- European Journal of Preventive Cardiology
- Published
- 2024-12-20
- DOI
- https://doi.org/10.1093/eurjpc/zwae399
- Citations
- 5
- Primary Topic
- Antiplatelet Therapy and Cardiovascular Diseases
- Type
- article
- Field-Weighted Citation Impact
- 2.01
Funders
- Deutsche Herzstiftung